FRANK MASINO: Open Payments
NPI 1346403748 · WEST READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 35 payments from 11 companies in 2025. Trend: 2023 $830 · 2024 $891 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $169 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 3 | $89 |
| ABBVIE INC. | 3 | $63 |
| Alkermes, Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Lundbeck LLC | 2 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: REXULTI, FANAPT, VRAYLAR, LYBALVI, CAPLYTA, COBENFY, SPRAVATO, INGREZZA.
Industry payments across PA — which companies pay providers there.
